JP2014111672A5 - - Google Patents

Download PDF

Info

Publication number
JP2014111672A5
JP2014111672A5 JP2014056829A JP2014056829A JP2014111672A5 JP 2014111672 A5 JP2014111672 A5 JP 2014111672A5 JP 2014056829 A JP2014056829 A JP 2014056829A JP 2014056829 A JP2014056829 A JP 2014056829A JP 2014111672 A5 JP2014111672 A5 JP 2014111672A5
Authority
JP
Japan
Prior art keywords
derivatives
pharmaceutical composition
alcohol
pyrrolidone
poe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014056829A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014111672A (ja
JP6215102B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014056829A priority Critical patent/JP6215102B2/ja
Priority claimed from JP2014056829A external-priority patent/JP6215102B2/ja
Publication of JP2014111672A publication Critical patent/JP2014111672A/ja
Publication of JP2014111672A5 publication Critical patent/JP2014111672A5/ja
Application granted granted Critical
Publication of JP6215102B2 publication Critical patent/JP6215102B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014056829A 2012-09-14 2014-03-19 医薬組成物 Expired - Fee Related JP6215102B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014056829A JP6215102B2 (ja) 2012-09-14 2014-03-19 医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012203293 2012-09-14
JP2012203293 2012-09-14
JP2014056829A JP6215102B2 (ja) 2012-09-14 2014-03-19 医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013176862A Division JP5686874B2 (ja) 2012-09-14 2013-08-28 医薬組成物

Publications (3)

Publication Number Publication Date
JP2014111672A JP2014111672A (ja) 2014-06-19
JP2014111672A5 true JP2014111672A5 (cg-RX-API-DMAC7.html) 2016-09-23
JP6215102B2 JP6215102B2 (ja) 2017-10-18

Family

ID=49226452

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013176862A Expired - Fee Related JP5686874B2 (ja) 2012-09-14 2013-08-28 医薬組成物
JP2014056829A Expired - Fee Related JP6215102B2 (ja) 2012-09-14 2014-03-19 医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013176862A Expired - Fee Related JP5686874B2 (ja) 2012-09-14 2013-08-28 医薬組成物

Country Status (7)

Country Link
US (1) US20150238606A1 (cg-RX-API-DMAC7.html)
EP (1) EP2895164A1 (cg-RX-API-DMAC7.html)
JP (2) JP5686874B2 (cg-RX-API-DMAC7.html)
CN (1) CN104619320A (cg-RX-API-DMAC7.html)
IN (1) IN2015DN02377A (cg-RX-API-DMAC7.html)
RU (1) RU2621615C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014042043A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102387786B (zh) 2009-04-09 2015-09-09 宝丽制药股份有限公司 抗真菌药物组合物
JP5688405B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
US8952044B2 (en) 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102933201B (zh) 2010-06-11 2015-12-16 宝丽制药股份有限公司 抗真菌药物组合物
JP6265624B2 (ja) * 2012-05-11 2018-01-24 ロート製薬株式会社 ルリコナゾール含有外用医薬組成物
US9012484B2 (en) 2012-09-14 2015-04-21 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
CN104619704B (zh) 2012-09-14 2017-12-05 宝丽制药股份有限公司 表面自由能用于分化评价晶体的用途，基于表面自由能作为指标评价的晶体，以及通过包含所述晶体制备的药物组合物
RU2603963C2 (ru) 2012-09-14 2016-12-10 Пола Фарма Инк. Кристалл, обладающий кристаллическими габитусами, и фармацевтическая композиция, полученная обработкой данного кристалла
JP5460797B1 (ja) * 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP6503627B2 (ja) * 2013-03-28 2019-04-24 大正製薬株式会社 医薬液体組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP6242655B2 (ja) * 2013-10-29 2017-12-06 リンテック株式会社 機能性物質の放出方法、機能性物質の放出用キット及び放出性組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
BR112018074143A2 (pt) * 2016-05-25 2019-04-16 Glenmark Pharmaceuticals Ltd composição tópica estável e método de tratamento de infecções fúngicas
CN107865825B (zh) * 2016-09-28 2022-05-20 四川海思科制药有限公司 一种卢立康唑外用喷雾剂药物组合物及其制备方法
WO2018179170A1 (ja) * 2017-03-29 2018-10-04 日本農薬株式会社 感染症を治療するための医薬組成物
CN111295202B (zh) * 2017-10-30 2022-07-08 科研制药株式会社 治疗甲癣的外用制剂
CN108143711A (zh) * 2018-01-13 2018-06-12 天津双硕医药科技有限公司 一种含有卢立康唑的外用乳膏组合物
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
CN113774390B (zh) * 2021-08-12 2023-08-04 上海新阳半导体材料股份有限公司 一种用于化学机械抛光后的清洗液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006339841B2 (en) 2006-03-08 2012-08-30 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
BRPI0621446C1 (pt) 2006-03-08 2021-05-25 Nihon Nohyaku Co Ltd composição farmacêutica para uso externo
RU2415669C2 (ru) 2006-03-08 2011-04-10 Нихон Нохияку Ко., Лтд. Фармацевтическая композиция для наружного применения
WO2009028495A1 (ja) * 2007-08-27 2009-03-05 Nihon Nohyaku Co., Ltd. 真菌性皮膚炎用剤
WO2009031643A1 (ja) * 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌組成物
CN101808639B (zh) 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
KR20100075475A (ko) * 2007-09-05 2010-07-02 가부시키가이샤 폴라 파마 의약 조성물
US20090130232A1 (en) * 2007-11-20 2009-05-21 Mohammed Zahra Composition and method for treatment of oral inflammation an ulceration
US8445717B2 (en) * 2008-11-20 2013-05-21 Chd Bioscience, Inc. α-Keto alkylperacids and methods for producing and using the same
EP2395839B1 (en) * 2009-02-13 2014-05-07 Topica Pharmaceuticals, Inc Anti-fungal formulation
CN102387786B (zh) * 2009-04-09 2015-09-09 宝丽制药股份有限公司 抗真菌药物组合物
JP5688405B2 (ja) * 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
US8952044B2 (en) * 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102933201B (zh) * 2010-06-11 2015-12-16 宝丽制药股份有限公司 抗真菌药物组合物
AU2012219321C1 (en) * 2011-02-17 2016-02-04 Armis Biopharma, Inc. Compositions comprising peroxy alpha-ketocarboxylic acid and methods for producing and using the same

Similar Documents

Publication Publication Date Title
JP2014111672A5 (cg-RX-API-DMAC7.html)
JP2014074012A5 (cg-RX-API-DMAC7.html)
RU2015108930A (ru) Фармацевтическая композиция, содержащая луликоназол
JP2014509655A5 (cg-RX-API-DMAC7.html)
JP2012523410A5 (cg-RX-API-DMAC7.html)
MX2017009489A (es) Composicion auto-emulsionante de acido graso ?3.
MX2015011074A (es) Composicion que comprende un compuesto lipido, un triglicerido y un tensioactivo, y metodos de uso de la misma.
HRP20210183T1 (hr) 18f-obilježeni inhibitori specifičnog membranskog antigena prostate (psma) i njihova uporaba kao sredstava za vizualizaciju raka prostate
MX2018003035A (es) Formulacion liquida de un dispositivo de vapor electronico.
JP2014129360A5 (cg-RX-API-DMAC7.html)
MX2016000307A (es) Farmaco para el tratamiento de la esteatosis hepatica no alcoholica.
PH12016500100A1 (en) Self-emulsifying composition of omega3 fatty acid
JP2016511753A5 (cg-RX-API-DMAC7.html)
EP4585270A3 (en) Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same
RU2015136849A (ru) Композиции, содержащие 15-он эпк, и способы их применения
MY180680A (en) Solid preparation
JP2014218522A5 (cg-RX-API-DMAC7.html)
RU2020123899A (ru) Новые соединения, ингибирующие mtor
JP2013525485A5 (cg-RX-API-DMAC7.html)
RU2016137349A (ru) Успокоительный феромон для кошек
MX387019B (es) Formulacion farmaceutica parenteral que contiene acido carglumico.
CL2015002832A1 (es) Formulación farmaceutica que comprende fosfatidilcolina para el tratamiento de colitus ulcerosa.
JP2016538288A5 (cg-RX-API-DMAC7.html)
JP2016079180A5 (cg-RX-API-DMAC7.html)
JP2018095567A5 (cg-RX-API-DMAC7.html)